Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to investment for life sciences companies – and try to restore Europe's global presence ...

Fundraising for healthcare venture capitalists these days is a slog—but some are overcoming a tough market to corral new investment pools. U.S. healthcare VCs raked in capital during the pandemic, ...

Chris Dixon, a managing partner at a16z crypto, said that non-financial use cases in crypto will flourish when regulations become clear. Prominent crypto venture capitalists are clashing online about ...

Deal volumes are down, and the sector has slipped in funding rankings, even as the market heads towards $37 Bn+ by 2030 Marquee rounds like Innovaccer and PharmEasy have kept total funding steady, but ...

Publisher Toge Productions and A Space for the Unbound developer Mojiken Studio have announced WORK WORK WORK, a point-and-click puzzle exploration game with ARG elements coming to PC via Steam. A ...

Toge Productions has released Toge Greenhouse 2023 game jam titles Project KILLDANCE, Project Homecoming Haven, and Party Party Anxiety for PC via Steam, free of charge. Toge Greenhouse is an internal ...

As venture capitalists become more purpose-driven, businesses need to be aware of the traits they expect to see in founders they see a future with. Venture investors are shifting focus to purpose-led ...

As pitches from founders come flooding in, one investor has revealed how VCs use a historic "law" to identify the best investments. "The power law in venture capital basically means that a small ...

Venture capital-backed firms in Europe are on track for their worst year of fundraising since 2015, as investors avoid putting money in an industry that’s struggled with returns. Venture funds based ...

Web3 promises an internet owned by its users, when in reality, the cash behind it now resembles a carnival barker’s till. Regulators are accelerating enforcement, courts are handing down multi-year ...

U.S. venture capitalists are racing to tap in to China’s growing biotechnology prowess, a shift moving the industry into a more global market for the most promising new drug candidates. Several ...